Lung Cancer News
Top Stories
New Genetic Techniques To Combat Lung Cancer
POSTED: May 2, 2008New results on genetic techniques that are helping doctors diagnose and treat lung cancer were released at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland. In one report (Abstract No. 81O; Friday ...
Mutation Database Helps Personalized Treatment Of Lung Cancer
POSTED: May 2, 2008A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, ...
Analysis Shows Combining Sorafenib With Carboplatin/paclitaxel Adds No Benefit In Lung Cancer
POSTED: May 2, 2008A clinical trial evaluating the benefit of adding the drug sorafenib to the combination of carboplatin/paclitaxel chemotherapy for lung cancer patients has been stopped based on results from an interim analysis, after an independent data monitoring committee concluded that the study would not meet its primary endpoint of improved overall survival. In a ...
Viruses May Play A Role In Lung Cancer Development
POSTED: May 2, 2008Papers presented at the 1st European Lung Cancer Conference, jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland highlight emerging evidence that common viruses may contribute to the development of lung cancer. Experts agree that smoking is...
Proteolix Initiates Phase 2 Clinical Trial Of Carfilzomib In Patients With Relapsed Solid Tumors
POSTED: May 2, 2008SOUTH SAN FRANCISCO, Calif. -- Proteolix, Inc. today announced that patient dosing has commenced in a Phase 2 clinical trial of carfilzomib (PR-171), a selective blocker of proteasome activity, in relapsed solid tumors. A Phase 1b dose-escalation trial of carfilzomib in patients with advanced solid tumors has recently been completed. The Phas...
Scientists Design A Virtual Pregnant Woman To Study Radiation's Effects
POSTED: April 29, 2008Destroying a tumor in a body with radiation poses a number of challenges and risks, especially for a pregnant woman and her fetus. Researchers at Rensselaer Polytechnic Institute are working to reduce those risks by advancing computer techniques that use virtual models of the human body. Their latest research looks at ways to protect a developing...
Egg Breakthrough Could Preserve Fertility
POSTED: April 25, 2008Scientists in Scotland yesterday revealed a major breakthrough in helping to preserve women's fertility. A team from Edinburgh University have succeeded in taking early stage follicles from a woman's ovaries and maturing them into eggs in the lab for the first time. The discovery should help women undergoing cancer treatment, or those wish...
High-intensity Chemotherapy Does Not Improve Survival In Small Cell Lung Cancer
POSTED: April 18, 2008Small cell lung cancer (SCLC) patients treated with high-dose chemotherapy did not have better survival rates than those treated with standard doses, according to a randomized controlled trial published online April 8 in the Journal of the National Cancer Institute. SCLC accounts for nearly 13 percent of lung cancer cases in the United States. Although ...
Exposure To Low Levels Of Radon Appears To Reduce The Risk Of Lung Cancer
POSTED: April 18, 2008Exposure to levels of radon gas typically found in 90 percent of American homes appears to reduce the risk of developing lung cancer by as much as 60 percent, according to a study published in the March 2008 issue of the journal Health Physics. The finding differs significantly from the results of previous case-control studies of the effects of low-leve...
Research Supports Role Of Inflammation To Determine Lung Cancer Risk, Particularly In African-American Women
POSTED: April 15, 2008SAN DIEGO -- Researchers at the Barbara Ann Karmanos Cancer Institute in Detroit today presented findings that support the role of inflammation in determining lung cancer risk, particularly among African-American women. The abstract titled, Cytokine SNPs Differentially Predict Risk of Non Small Cell Lung Cancer in African American and Caucasian...
